Technical Analysis for GRTS - Gritstone Oncology, Inc.

Grade Last Price % Change Price Change
D 14.18 5.35% 0.72
GRTS closed up 5.35 percent on Wednesday, February 24, 2021, on 16 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical GRTS trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Hammer Candlestick Bullish 5.35%
Stochastic Buy Signal Bullish 5.35%
1,2,3 Pullback Bullish Bullish Swing Setup 5.35%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 5.35%
Wide Bands Range Expansion 5.35%
Gapped Down Weakness 5.35%
Lower Bollinger Band Touch Weakness 5.35%
Oversold Stochastic Weakness 5.35%
Older End-of-Day Signals for GRTS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Resistance about 19 hours ago
Non-ADX 1,2,3,4 Pullback Entry about 19 hours ago
1,2,3, Pullback Entry about 19 hours ago
Hammer Candlestick Entry about 19 hours ago
Rose Above Previous Day's High about 19 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight multiple cancer types. The company has built its tumor-specific immunotherapy approach on two key pillars—first, a proprietary machine learning-based platform, Gritstone EDGE™, which provides a powerful ability to predict from a routine tumor biopsy the tumor-specific neoantigens, or TSNA, that are presented on a patient’s tumor cells; and second, the ability to develop and manufacture potent immunotherapies utilizing patients’ TSNA to drive the patient’s immune system to attack and destroy tumors.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Medicine Immune System Immunotherapy Oncology Cancer Immunotherapy Virotherapy Immunotherapies Machine Learning Tumors Biopsy Tumor Cell Active Immunotherapy

Is GRTS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 35.03
52 Week Low 2.538
Average Volume 3,688,100
200-Day Moving Average 5.91
50-Day Moving Average 11.24
20-Day Moving Average 15.62
10-Day Moving Average 14.55
Average True Range 1.79
ADX 44.03
+DI 31.60
-DI 21.35
Chandelier Exit (Long, 3 ATRs ) 22.87
Chandelier Exit (Short, 3 ATRs ) 17.57
Upper Bollinger Band 18.09
Lower Bollinger Band 13.16
Percent B (%b) 0.21
BandWidth 31.55
MACD Line 0.37
MACD Signal Line 1.01
MACD Histogram -0.6453
Fundamentals Value
Market Cap 535.49 Million
Num Shares 37.8 Million
EPS -3.21
Price-to-Earnings (P/E) Ratio -4.42
Price-to-Sales 33.81
Price-to-Book 1.72
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.98
Resistance 3 (R3) 15.95 15.33 15.68
Resistance 2 (R2) 15.33 14.87 15.34 15.58
Resistance 1 (R1) 14.75 14.59 15.04 14.78 15.48
Pivot Point 14.13 14.13 14.27 14.14 14.13
Support 1 (S1) 13.55 13.67 13.84 13.58 12.88
Support 2 (S2) 12.93 13.39 12.94 12.78
Support 3 (S3) 12.35 12.93 12.68
Support 4 (S4) 12.38